GBS is a rare condition in which a person's immune system attacks the peripheral nerves, resulting in muscle weakness, loss of sensation in the legs and/or arms, as well as problems swallowing or ...

Officials said that the tally of suspected and confirmed Gullain-Barre Syndrome (GBS) cases in Maharashtra reached 211 on ...

The tally of suspected and confirmed Gullain-Barre Syndrome cases in Maharashtra reached 211 on Tuesday with the detection of ...

The tally of suspected and confirmed Gullain-Barre Syndrome (GBS) cases in Maharashtra reached 211 on Tuesday with the ...

Maharashtra has reported 211 cases of Gullain-Barre Syndrome, a serious nerve disorder. Out of these, 183 cases have been confirmed. The condition affects the peripheral nerves causing muscle weakness ...

Axogen, Inc. (NASDAQ:AXGN) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Axogen, Inc., together with its subsidiaries, develops and ...

French clinical-stage biotech AlgoTherapeutics (AlgoTx) today announced the completion of its 276 patient Phase II trial, known as ACT, with ATX01 in chemotherapy-induced peripheral neuropathy (CIPN).

AlgoTherapeutix (AlgoTx), a clinical stage biotechnology company developing a first-in-class therapeutic for peripheral ...

Although GBS cannot always be prevented, maintaining a healthy diet can help reduce the risk of infections and support nerve ...